Heparin-induced thrombocytopenia successfully treated with fondaparinux.

Abstract

We report the successful treatment of a patient with HIT-associated venous thrombosis by fondaparinux, a synthetic pentasaccharide. Although not yet approved for this indication, this new anticoagulant may be a useful alternative in the setting of HIT. 

Topics

  • Presentations referencing similar topics